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Abstract The alpha-kinase family represents a class of
atypical protein kinases that display little sequence simi-
larity to conventional protein kinases. Early studies on
myosin heavy chain kinases in Dictyostelium discoideum
revealed their unusual propensity to phosphorylate serine
and threonine residues in the context of an alpha-helix.
Although recent studies show that some members of this
family can also phosphorylate residues in non-helical
regions, the name alpha-kinase has remained. During
evolution, the alpha-kinase domains combined with many
different functional subdomains such as von Willebrand
factor-like motifs (vWKa) and even cation channels
(TRPM6 and TRPM7). As a result, these kinases are
implicated in a large variety of cellular processes such as
protein translation, Mg
2? homeostasis, intracellular trans-
port, cell migration, adhesion, and proliferation. Here, we
review the current state of knowledge on different mem-
bers of this kinase family and discuss the potential use of
alpha-kinases as drug targets in diseases such as cancer.
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Introduction
The reversible phosphorylation of proteins catalyzed by
protein kinases and phosphatases is one of the principal
regulatory mechanisms of signal transduction. Kinase
regulated signaling cascades control a large variety of
cellular functions and physiological processes such as
transcription, protein translation, DNA replication and
repair, cell adhesion, and cell migration as well as cell
growth and proliferation. As a consequence, defects in
protein phosphorylation are frequently associated with the
pathogenesis of human diseases including cancer, diabetes,
and inﬂammatory disorders. Owing to their well-deﬁned
catalytic properties, kinases represent one of the most
favored groups of drug targets of the pharmaceutical
industry. To identify novel speciﬁc kinase inhibitors and
facilitate translational research into the use of such drugs, a
detailed understanding of the regulation and function of
kinases and their substrates is essential.
The protein kinase-like superfamily consists of a large
collection of proteins sharing functional properties that
allow them to catalyze the transfer of phosphate from ATP
to a variety of substrates including proteins and lipids [1].
The majority (90%) of protein serine/threonine and tyro-
sine kinases are classiﬁed as conventional protein kinases
(CPKs) since they possess a common architecture within
the catalytic domain. The remaining protein kinases (about
10%), which display little sequence similarity to CPKs, are
referred to as atypical protein kinases (APKs) and include
protein kinases related to histidine kinases from bacteria,
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kinases. Phylogenic studies point out that both CPKs and
APKs are broadly distributed in prokaryotes and eukary-
otes [2]. In addition, the ancient origin of both groups of
kinases suggest that APKs developed in parallel with CPKs
and do not simply represent modiﬁed CPKs. However, a
speciﬁc subfamily of APKs known as alpha-kinases is
exceptional in that it appeared recently in evolution and
therefore displays a distribution limited to eukaryotes [2,
3]. Scheeff and Bourne hypothesized that alpha-kinases
developed to provide a novel signaling capacity within
more complex eukaryotic organisms [2]. Here, we high-
light the research performed on alpha-kinases to date and
their potential involvement in human disease.
Alpha-kinases, a novel class of protein kinases
Alpha-kinases were ﬁrst recognized as a novel class within
the protein kinase superfamily by Ryazanov and colleagues
[4] after earlier publications on the identiﬁcation and
characterization of the Dictyostelium myosin heavy chain
kinase A (MHCK-A), B (MHCK-B), and C (MHCK-C) [5–
7]. Following the cloning of human, mouse, rat and Cae-
norhabditis elegans eukaryotic elongation factor-2 kinase
(eEF2K, previously known as CaMKIII) [8], sequence
analysis revealed a surprising lack of sequence similarity to
known protein kinases [4]. However, its catalytic domain
was found to be strikingly similar to that of the Dictyos-
telium MHCKs, suggesting the existence of a new class of
protein kinases with a novel catalytic domain structure [8].
The cloning of several alpha-kinases allowed for the rapid
identiﬁcation of other members of this kinase family in
various genomes [1, 4] (Fig. 1).
The alpha-kinase family was named after the unique
mode of substrate recognition by its initial members, the
Dictyostelium heavy chain kinases. In contrast to the target
sites of CPKs, which are usually located within loops,
b-turns, or irregular structures [9], the substrate residues
targeted by MHCKs were found to be located within pro-
tein sequences that adopt an alpha-helical conformation
[10, 11]. However, recent in vitro data suggest that this is
not the consensus as multiple alpha-kinases were found to
also target residues in non-helical regions [12, 13]. Cur-
rently, alpha-kinases represent a family of atypical protein
kinase with a unique catalytic domain architecture
homologous to the Dictyostelium discoideum MHCKs.
Determinants for substrate recognition remain largely
unknown, although the necessity of a basic residue fol-
lowing the phosphoacceptor aminoacid has been shown
previously [14].
To date six human alpha-kinases have been identiﬁed. In
addition to eEF2K, the human genome encodes alpha-
kinase 1 (lymphocyte alpha-kinase, LAK or ALPK1),
alpha-kinase 2 (heart alpha-kinase, HAK or ALPK2), and
alpha-kinase 3 (muscle alpha-kinase, MAK or ALPK3),
initially named after the tissue in which they were identi-
ﬁed [4]. The remaining two mammalian alpha-kinases,
TRPM6 and TRPM7, represent cation channels belonging
to the TRP ion channel family.
The alpha-kinases found in man are widely distributed
among vertebrates. In contrast to the other human alpha-
kinase containing proteins, eEF2K can also be found in
invertebrates such as the metazoan Trichoplax adhaerens
and in the diatom Thalassiosira pseudonana, indicating
that eEF2K represents the oldest alpha-kinase within the
vertebrates. According to the phylogenetic tree, eEF2K
appears to be most closely related to the Dictyostelium
discoideum MHCKs, especially to MHCK-B and MHCK-C,
consistent with the unique N-terminal localization of their
alpha-kinase domains (Fig. 1; Table 1). The four Dicty-
ostelium MHCKs share many structural and functional
features which is supported by their isolated position in
the phylogeny [7, 15–19]. The closely related Dictyoste-
lium alpha-kinase 1 (AK1) contains an N-terminal Arf-
GAP domain [19] and is, like the MHCKs, speciﬁcally
expressed by Dictyostelium discoideum, indicating taxon
speciﬁc gene duplications and recombination. As AK1 has
not been functionally characterized, it will not be dis-
cussed in depth. In the ciliate Tetrahymena thermophila,
gene ampliﬁcation of alpha-kinases is evident as its gen-
ome encodes eight very similar alpha-kinases with an
N-terminal von Willebrand factor A motif. Another
striking example is the collection of alpha-kinases enco-
ded by the genome of Entamoeba histolytica which
includes many different domain architectures, including
proteins with SH3 and p53-like domains [20]. This phy-
logenetic tree contains a number of alpha-kinases which
are neither highlighted (Fig. 1) nor discussed in Table 1 as
they have no typical subdomain organization and have yet
to be characterized. Overall, we postulate that the diver-
gent family of alpha-kinases arose by independent taxon
speciﬁc gene duplications and recombination with a
variety of subdomains.
Elucidation of the crystal structure of the TRPM7 kinase
domain by Yamaguchi and colleagues led to the striking
observation that, despite a lack of sequence similarity, the
alpha-kinase catalytic core has an architecture related to
that of CPKs [21]. CPKs and alpha-kinases share a
remarkably similar N-terminal lobe that predominantly
folds into a curved b-sheet and contains the phosphate
binding loop (P-loop). The C-terminal lobe, however,
might appear to be more divergent although in both cases it
largely consists of alpha-helices and the activation loop can
easily be distinguished (Fig 2a). The interlobe cleft serves
as binding pocket for ATP and contains well-conserved key
876 J. Middelbeek et al.catalytic residues, such as invariant lysine- (K1648 in
TRPM7) and aspartate- (D1767, D1777 in TRPM7), that
are located in similar positions to position the ATP and
coordinate Mg
2? ions (Figs. 2b and 3).
Although the ATP binding pockets of CPKs and alpha-
kinases are structurally very alike, the nature of inter-
actions between the kinase and base and sugar moieties of
ATP differ signiﬁcantly and may also differ within the
alpha-kinase family itself [21]. One striking difference is
the localization of the conserved GXGXXG motif which,
in CPKs, is positioned within the catalytic P-loop and
serves to bind phosphates. Although alpha-kinases do
contain a similar glycine rich motif, it is not located
within the P-loop but in another loop proximal to the
C-terminus (Fig. 3). This loop structurally resembles the
activation loop in CPKs which is involved in peptide
substrate recognition, suggesting a similar function for the
glycine rich motif in alpha-kinases [21]. The different
modes of substrate recognition between alpha-kinases and
CPKs may explain the distinct set of alpha-kinase
substrates.
Another major distinction between alpha-kinases and
CPKs is the presence of a zinc-ﬁnger motif within the
C-terminus of alpha-kinases (Figs. 2c and 3). This motif
coordinates a zinc ion and is thought to play an important
role in stabilizing the tertiary structure of the catalytic core.
Indeed, mutation of the conserved cysteine residues
(C1812, C1816 in TRPM7) abrogates kinase activity [22,
23]. For an in-depth comparison between the structures of
alpha-kinases and CPKs, see review in [3].
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Fig. 1 Phylogenetic analysis of the alpha-kinase family. A PSI-Blast
[152] search was done, starting with the TRPM7 alpha-kinase domain
and using three iterations, to detect all sequenced alpha-kinases. For
those sequences that were detected with PSI-Blast, but that were not
detected as having an alpha-kinase domain by SMART [151],
reciprocal PSI-Blast searches were performed to ensure that they were
indeed homologous alpha-kinases. From the results, species were
included so that the major eukaryotic taxa with alpha-kinases would
be represented in the tree. Selected sequences were then aligned using
ClustalW2 [153]. A phylogenetic tree was generated using PHYML
[154] as implemented in Seaview [155]. Bootstrap values of the major
branches are indicated. The dashed line separates vertebrate from
invertebrate alpha-kinases. Red branches indicate N-terminal alpha-
kinases. Alpha-kinases with a typical subdomain architecture are
indicated in the colors that refer to the schematic representations in
Table 1
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Myosin heavy chain kinases in Dictyostelium
Tight regulation of myosin II induced contractility is
essential for processes like cytokinesis and cell migration.
Myosin II regulation by light chain phosphorylation has
been described in many eukaryotic systems and is well
known to regulate activity of the myosin motor domain
[24]. A role for myosin II heavy chain phosphorylation in
regulating myosin II activity and function was initially
established in lower eukaryotes such as Dictyostelium and
Acanthamoeba [25–28]. The incorporation of phosphate
into the Dictyostelium myosin heavy chain, residues
Thr1823 [11], Thr1833 and Thr2029 [10], inhibits its ability
to self-assemble into bi-polar ﬁlaments, which is required
for the generation of contractile forces [26]. Mutagenesis of
these residues into non-phosphorylatable alanines (3*Ala)
induces overassembly of myosin II proteins, severely
affecting polarization, chemotaxis, and cytokinesis [28, 29].
In search of protein kinases responsible for heavy chain
phosphorylation in Dictyostelium, MHCK-A was identiﬁed
in actomyosin precipitations and shown to speciﬁcally
incorporate phosphate into the alpha-helical myosin heavy
chain [15]. Thereby, MHCK-A reduced the ﬁlament form-
ing properties of myosin II and inhibited overall myosin II
function [15, 26, 28, 30]. Cloning of MHCK-A revealed
three separate domains (Table 1). A coiled-coil N-terminal
region (*500aa) is involved in the heteromerization of the
kinase [31] and required for MHCK-A translocation to
actin-rich cell regions such as the cortex. Moreover, it
directly interacts with actin ﬁlaments in vitro which
increases its kinase activity *40-fold [32, 33]. More
recently, actin crosslinking was shown to be an additional
feature of this domain [34]. This suggests that, in addition to
driving myosin II disassembly, MHKC-A may also affect
the actin-myosin cytoskeleton by crosslinking actin ﬁla-
ments. The second domain represents the catalytic domain
(*aa550–800), which showed no homology to known
eukaryotic protein kinases [5, 6]. Finally, the C-terminus
contains a stretch of seven WD-repeats that generally
coordinate multi-protein complex assemblies [35]. Steimle
and colleagues showed that the MHCK-A WD-repeat
domain binds directly to the myosin heavy chain and
thereby targets the kinase towards its substrate [36]. Neither
Fig. 2 Alpha-kinases: structure and conservation. a Crystal structure
of TRPM7 as determined by Yamaguchi et.al. [21]. N-terminus (N)
refers to residue G1579 in the human TRPM7 amino acid sequence.
Please note that this residue corresponds to G1577 in the mouse
sequence. Indicated are domains that resemble the N-terminal lobe
(containing P-loop), C-terminal lobe (containing activation loop) and
interlobe cleft of CPKs. Conserved residues within the alpha-kinase
family (Fig. 3) are indicated in red. b The well-conserved interlobe
cleft functions as ATP binding pocket. The ATP molecule (yellow)i s
positioned within the binding pocket by multiple residues that are
well conserved within the alpha-kinase family (red). The indicated
residue identities refer to the human TRPM7 amino acid sequence
(Fig. 3). c Typical zinc-ﬁnger domain within the C-terminal lobe of
alpha-kinases. Residues that bind the zinc molecule (green) are well
conserved between the alpha-kinase family members (red). The
indicated residue identities refer to the human TRPM7 amino acid
sequence (Fig. 3)
b
The alpha-kinase family 879the N-terminal coiled-coil domain nor the WD-repeats are
required for catalytic activity [6]. However, these domains
are essential in substrate phosphorylation which is strongly
enhanced by autophosphorylation of the region that links
the coiled-coil region to the catalytic core (aa500–550)
[6, 37].
Apart from MHKC-A, the Dictyostelium genome
encodes three additional myosin heavy chain kinases,
MHCK-B, MHCK-C, and MHCK-D [7, 16, 38], with a
catalytic domain very similar to that of MHCK-A. Each of
these MHCK isoforms contains a C-terminal WD domain,
but in contrast to MHCK-A, MHCK-B, and MHCK-C lack
the large N-terminal coiled-coil region (Table 1). Although
MHCK-D remains functionally uncharacterized to date, it
does contain this coiled-coil region and, according to
sequence similarity, it appears to be the closest relative of
MHCK-A (Fig. 1). MHCKA, B, and C share many bio-
chemical features. Kinase activity is regulated by
autophosphorylation [17, 37, 39] and all three speciﬁcally
target threonine residues within the myosin heavy chain in
<40%
>40%
>60%
>80%
Conservation
Beta-sheet
Alpha-helix
Fig. 3 Sequence alignment of Dictyostelium and human alpha-
kinases. Dictyostelium and human alpha-kinase amino acids
sequences corresponding to the human TRPM7 alpha-kinase domain
(G1579-T1830) were aligned using ClustalW2 sequence alignment
software [153]. Names and species, Dictyostelium discoideum (Dd),
Homo sapiens (Hs) are indicated on the left. Conservation of speciﬁc
residues within this group of alpha-kinases, corrected for missing
sequences, is indicated by shadings of blue and a barchart supporting
the alignement (0 not conserved, 100 fully conserved). Red bars
represent fully conserved residues and are indicated red in Fig. 2.
Sequences representing the P-loop and GXGXXG motif are indicated
on top. The indicated residue identities refer to the human TRPM7
amino acid sequence
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16–19]. MHCK-A, B, and C triple gene knockouts induce
myosin II overassembly and severely affect cytokinesis,
resembling the phenotypes observed when MHC phos-
phorylation was inhibited by substituting the targeted
residues with alanine (3*Ala) [19, 28]. Overexpression of
MHCK-A, B, and C, on the other hand, also results in
impaired cytokinesis by hyperphosphorylation of myosin II
inducing myosin II ﬁlament disassembly [30, 39, 40].
In spite of these similarities, the spatial regulation of the
MHCK isoforms differs signiﬁcantly, indicating speciﬁc
functions for each isoform. Both MHCK-A localization
and activity appear to be actin dependent [32, 41, 42]. In
response to stimulation by chemoattractants such as cAMP,
MHCK-A is enriched in the actin-rich leading edge of the
cell where it disassembles myosin II ﬁlaments [41].
MHCK-A might thus provide a mechanism by which
myosin II is locally inactivated, allowing actin based cel-
lular protrusions such as lamellipodia and phagocytic cups
to be formed. Hence, MHCK-A plays an important role in
maintaining cell polarity, chemotaxis and cell migration
[29]. Both MHCK-B and C are enriched in the contractile
ring during late cytokinesis, driving myosin II disassembly
for efﬁcient cell division. In addition, MHCK-C is enriched
in the posterior region of moving cells where it could play a
role in the disassembly of the actomyosin cytoskeleton and
myosin II recycling required for proper cell body translo-
cation [16, 17, 19, 38]. Notably, in contrast to MHCK-A,
MHCK-C distribution fully depends on myosin II [16, 17].
Altogether, these spatial differences indicate speciﬁc roles
for MHCK isoforms in ﬁne tuning the Dictyostelium
actomyosin cytoskeleton.
vWFa-kinase
vWFa-kinase (vWKa) is one of the more recently identi-
ﬁed alpha-kinases in Dictyostelium, carrying a kinase
catalytic domain (aa398–592 in Dictyostelium) similar to
the MHCKs. In contrast to MHCKs, however, it is broadly
expressed among invertebrates (Fig. 1), it phosphorylates
both threonine and serine residues [14], and has a distinct
domain organization (Table 1). It lacks the C-terminal
WD repeat domain and, consequently, the kinase domain
is located at the extreme C-terminus (Table 1). Further-
more, the protein contains an N-terminal vWFa motif
(aa121–233 in Dictyostelium)[ 40]. This domain is named
after its homology to von Willebrand factor A, a plasma
glycoprotein essential for proper blood clotting. The vWFa
domain mediates receptor-ligand binding, protein–protein
interactions, and multiprotein complex formation. Proteins
containing a vWFa domain are involved in cell adhesion
such as integrin–collagen interactions, but also in DNA
repair and transcription (reviewed in [43]). Like for the
heavy chain kinases in Dictyostelium, overexpression of
vWKa leads to multinucleation, indicative of defects in
cytokinesis due to disregulation of myosin II function [40].
Signiﬁcant myosin II overassembly was observed after
vWKA gene disruption, resembling the effect of MHCK
gene disruption and introducing non-phosphorylatable
threonine–alanine mutations into the myosin heavy chain
(3*Ala) [19]. This is consistent with the notion that vWKa
could be an additional myosin heavy chain kinase. How-
ever, several observations are in conﬂict with this
hypothesis. First, overexpression of vWKa increased
myosin II assembly [40]. Second, vWKa is unable to
phosphorylate the myosin II heavy chain in vitro, although
it autophosphorylates and has intrinsic catalytic activity
[40]. Surprisingly, both overexpression and gene disrup-
tion of vWKa increased the myosin II protein levels by
means of an unknown mechanism [40]. Altogether, these
results do indicate a role for vWKa in the regulation of
myosin II but not by direct phosphorylation of its heavy
chain. vWKa localizes to contractile vacuoles, organelles
involved in osmoregulation, and to the perinuclear golgi
apparatus [40]. Hence, it is highly unlikely that, although
varying vWKa expression levels affects growth kinetics,
cell division, and development, its function is restricted to
the dedicated functions of the previously identiﬁed
MHCKs.
eEF2-kinase
Eukaryotic elongation factor-2 kinase (eEF2K) is a regu-
lator of global protein synthesis. It phosphorylates
eukaryotic elongation factor-2 (eEF2), a ribosome binding
protein that catalyzes the movement of ribosomes along the
mRNA during translation in most eukaryotic cells [44].
Phosphorylation of eEF2 on threonine residues Thr56 and
Thr58 decreases its afﬁnity for ribosomes and inhibits the
global rate of protein synthesis [45–49]. As eEF2K activity
is Ca
2? and calmodulin dependent, it was initially classi-
ﬁed as a member of the Ca
2?/calmodulin-dependent
protein kinase family [48, 50]. However, sequence analysis
revealed no homology to the other Ca
2?/calmodulin kina-
ses. Instead, its sequence showed remarkable homology to
the previously described Dictyostelium MHCKs [8].
Additionally, eEF2K phosphorylates threonines whereas
the other members of the CaM-kinase family predomi-
nantly target serine residues [48]. Of note is a publication
by Jorgensen and colleagues showing that the targeted
threonine residues are not located within an alpha-helix, as
was determined by crystallography on the yeast eEF2 [12].
eEF2K comprises three functional domains (Table 1).
The catalytic domain (aa100–350) is ﬂanked at its N-ter-
minus by a calmodulin binding domain (aa51–96), while its
C-terminus contains the eEF2 binding domain (aa521–725)
The alpha-kinase family 881required for substrate targeting [23, 51]. Importantly, cat-
alytic activity of eEF2K requires the binding of calmodulin
to the calmodulin binding domain.
Since protein translation consumes a large amount of
energy, the cell must carefully balance the activity of
eEF2K with its need for protein translation. Therefore,
eEF2K activity is modulated through multisite phosphor-
ylation by kinases downstream of mTOR and AMPK, the
central sensors of cellular nutrients and energy levels [52–
56]. In the presence of sufﬁcient nutrients, its kinase
activity towards eEF2 is suppressed. Upon nutrient depri-
vation and hypoxia, the suppression of eEF2K is relieved
which results in the phosphorylation of eEF2 and, conse-
quently, inhibition of protein synthesis (reviewed in [55]).
eEF2K appears to be a major regulator of autophagy
downstream from mTOR, which, besides the common
degradation of organelles, serves as a cellular coping
strategy to deal with long-term nutrient deprivation [57,
58]. When cells are deprived of nutrients, they will con-
sume their own cytoplasmic content to obtain the energy
needed to survive [59, 60]. During this state of metabolic
stress, protein synthesis is inhibited by increased phos-
phorylation of eEF2 which terminates protein elongation
[58, 61]. This may be further enhanced by a decrease in pH
due to hypoxia which dramatically increases eEF2K
activity [62]. As a consequence, a cell becomes more
resistant to metabolic stress. An increased eEF2K activity
has been observed in many cancers and may promote
cancer cell survival, tumor growth and metastasis, pro-
cesses that require the cell to cope with hypoxia and
nutrient deprivation [57, 58, 63]. Moreover, silencing of
eEF2K was shown to sensitize tumor cells to treatments
that induce energy stress and cytotoxicity [64].
Another link between eEF2K and cancer is the close
relationship between eEF2/eEF2K activity during cell-
cycle progression (reviewed in [65]); during G1-phase, the
stage in which cell growth takes place, eEF2K is inactivated
and, consequently, eEF2 becomes active permitting protein
synthesis. During DNA replication in the S-phase, eEF2K
slowly dephosphorylates to fully inhibit eEF2 at the start of
the G2 and M phase, where proofreading and mitosis take
place. The common explanation for this decline in protein
synthesis is that cellular energy sources are to be redirected
from protein synthesis to proofreading and the actual cell
division. Various reports describe delayed cell cycle pro-
gression or a complete arrest by deregulation of eEF2 or
eEF2K [63, 66–68], which makes the eEF2/eEF2K pathway
an attractive drug target for cancer treatment.
Alpha-kinase 1, 2 and 3
The vertebrate alpha-kinase 1, 2, and 3 were initially
named after the tissues in which they were identiﬁed by
Ryazanov and colleagues [4, 69]; lymphocyte alpha-
kinase, heart alpha-kinase, and muscle alpha-kinase,
respectively. All three carry an alpha-kinase domain at
their extreme C-terminus that is particularly well conserved
between ALPK2 and ALPK3 (Table 1 and Fig. 1).
ALPK1 has been implicated in epithelial cell polarity
and exocytic vesicular transport towards the apical plasma
membrane [70]. ALPK1 resides on golgi-derived vesicles
where it phosphorylates myosin IA, an apical vesicle
transport motor protein that regulates the delivery of ves-
icles to the plasma-membrane [70]. To our knowledge, no
functional studies have been performed on ALPK2.
Expression of ALPK3, also known as myocytic induction/
differentiation originator (Midori), is restricted to fetal and
adult heart and adult skeletal muscle. Overexpression of
ALPK3 enhances differentiation of murine embryonic
carcinoma cells into cardiomyocytes. As ALPK3 localizes
to the nucleus, it is thought to act as a transcriptional
regulator implicated in early cardiac development [71].
TRPM6 and TRPM7
Transient receptor potential (TRP) cation channels make up
a large protein superfamily. Members of this family func-
tion as cellular sensors responding to stimuli such as
temperature, taste, touch, pain, osmolarity, and mechanical
stress [72–74]. TRPM6 and TRPM7 belong to the
melastatin-related subfamily of TRP (TRPM) channels,
which represents a group of eight proteins displaying a wide
range of structural features, expression patterns, ion selec-
tivity, gating properties, and functions [75]. Both TRPM6
and TRPM7 are unique in the sense that they encode
divalent cation channels fused to an alpha-kinase domain.
As these unusual channel-kinases have caught the attention
of electrophysiologists worldwide, their channel properties
have been studied in great detail. However, involvement of
the alpha-kinase domain in regulating channel function
remains subject to controversy. Before going into the pro-
posed functions of the alpha-kinase domain within these
channel-kinases, we will ﬁrst discuss the regulation and
function of their channel domains in cellular physiology.
Like other TRP channels, TRPM6 and TRPM7 possess
six transmembrane domains ﬂanked by large N- and
C-terminal tails that reside in the cytosol. Within the
N-terminal tail, four stretches of amino acids are present
which are conserved between the different members of the
TRPM subfamily but whose function is poorly understood
[75]. Proximal to the last transmembrane domain in the
C-terminal tail, there is the so-called TRP box, a conserved
stretch of amino acids present in all TRP ion channels. In
addition, there is a coiled-coil domain and, at the extreme
C-terminus, the alpha-kinase domain [3] (Table 1). The
transmembrane domains organize within the plasma
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short stretch of amino acids between the ﬁfth and sixth
transmembrane domains [76]. Functional channels are
most likely organized as either homo- or heterotetramers
which have their unique electrophysical properties and
functions [77–79]. The exact mechanism of tetramerization
is unknown. However, it has been demonstrated that sev-
eral TRP channels including TRPM2 and TRPM8 require
the presence of the coiled-coil domain for the assembly of
active channels [80, 81].
TRPM7 is highly similar to TRPM6 displaying 50%
identity at the amino acid level. Moreover, the kinase
domains share 75% of their aminoacid sequence. Both
channels are highly permeable to Mg
2? and Ca
2? [82, 83].
In spite of these similarities, these proteins appear to be
functionally non-redundant. While TRPM7 is ubiquitously
expressed, TRPM6 expression is mostly limited to brain,
intestine, and kidneys [84]. Knockout studies have shown
that both TRPM6 and TRPM7 are essential in development
as the loss of these channels is embryonic lethal [85, 86].
Moreover, overexpression of TRPM6 cannot rescue cell
growth arrest due to the ablation of TRPM7 [79]. Finally,
mutations in TRPM6 cause familial hypomagnesemia with
secondary hypocalcemia, a disease characterized by defects
in renal and intestinal Ca
2? and Mg
2? absorption which
progresses despite the expression of TRPM7 in both the
kidney and intestine [87, 88].
The importance for TRPM6 in maintaining whole body
Mg
2? levels, e.g. by renal Mg
2? reabsorbtion, is widely
accepted [82, 84, 89]. The role of TRPM7 in Mg
2?
homeostasis, however, remains controversial. Various
publications have implicated TRPM7 in the regulation of
cellular Mg
2? levels [83, 90, 91]. However, there is now
increasing evidence that, in contrast to TRPM6, the
TRPM7 channel might primarily be implicated in Ca
2?
signaling [86, 92, 93]. Initially, TRPM7 was thought to
mediate cellular Mg
2? homeostasis based on the growth
arrest in TRPM7-deﬁcient DT-40 B cells, which could be
restored by culturing these cells in media supplemented
with high Mg
2? [79, 83, 91]. However, in other cell types
such as retinoblastoma cells, defects in cell growth due to
loss of TRPM7 expression could not be reverted by the
addition of Mg
2? [92]. Several investigations implicate
TRPM7 in a number of other cellular functions including
anoxic cell death, exocytosis, mechanotransduction, cell
proliferation, cell adhesion, and cell migration [93–100],
processes that depend on TRPM7-mediated Ca
2? inﬂux
rather than involving Mg
2?. Importantly, it was recently
shown that TRPM7 was not essential for maintaining Mg
2?
levels in mice TRPM7 knockout thymocytes [86]. The
current opinion is that TRPM7 regulates local intracellular
Ca
2? concentrations and thereby affects the functioning of
Ca
2? sensitive proteins in its close proximity [94, 98, 101].
Channel opening is regulated via multiple mechanisms.
A unique feature of TRPM6 and TRPM7 channels is their
inhibition by intracellular Mg
2? [82, 83]. Furthermore,
cation conductance is regulated through signaling by
G-protein coupled receptors such as the bradykinin recep-
tor [102]. Additionally, TRP channels are well-known
mechanosensors. Their conducting properties are modu-
lated upon application of mechanical force which result in
a variety of cellular responses [103–105]. Consistently,
TRPM7 channel opening is regulated by mechanical force
[94, 96, 106].
The role of the TRPM6 and TRPM7 alpha-kinase
domain in mediating the inﬂux of cations is still under
debate. Both alpha-kinase domains have been suggested to
function as intracellular Mg
2? sensors that mediate channel
permeability [91, 107–110]. Additionally, the RACK1
scaffold protein inhibits Mg
2? conductance in a autopho-
sphorylation-dependent manner through binding of the
TRPM6 kinase domain [111]. Furthermore, the repressor of
estrogen receptor activity (REA) inhibits TRPM6 channel
opening in a similar manner. Of interest is the fact that the
interaction between REA and the alpha-kinase domain can
be abolished by estrogens, suggesting involvement of
estrogens in Mg
2? homeostasis [112]. In contrast, phos-
photransferase activity appears to be unrelated to channel
opening in the case of TRPM7. For instance, TRPM7
channels where the entire kinase domain has been deleted,
remain sensitive to inhibition by Mg
2?- and Mg
2?-nucle-
otide complexes [91, 110]. Furthermore, point mutations in
the TRPM7 kinase domain that abolish phosphotransferase
activity do not appear to affect TRPM7 channel gating [93]
and have only a minor effect on the inhibition of TRPM7
channel activity by Mg
2?- and Mg
2?-nucleotides [113].
Hence, the consensus in the ﬁeld is that the kinase activity
is not essential for opening of TRPM7 channels [114].
Instead, our work and that of others points towards an
alternative model where the opening of TRPM7 channels
affects kinase function. Since Ca
2? does not directly
inﬂuence kinase activity [115], we propose that a local
increase in Ca
2? concentration regulates the recruitment/
targeting of TRPM7 substrates [116].
Rather than modulating channel opening, the TRPM7
kinase domain transmits intracellular signals via the
phosphorylation of downstream targets such as annexin 1
in a Ca
2?-dependent manner. Annexin 1, a member of the
annexin phospholipid binding family, binds Ca
2? which
leads to a conformation change exposing the target residue
to the TRPM7 kinase domain [117]. Although annexins are
known to be involved in Ca
2?-dependent actin dynamics
and membrane subdomain organization [118], the physio-
logical relevance of the TRPM7-annexin 1 interaction
remains to be elucidated. TRPM7 function has been linked
to vascular remodeling. Stimulation of vascular smooth
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receptor agonist bradykinin increases TRPM7 expression,
autophosphorylation (indicative of kinase activity [116]),
channel opening, annexin 1 activity, and cell migration
[119, 120]. These ﬁndings appear to connect TRPM7
channel opening (Mg
2? and Ca
2? inﬂux), kinase activity,
and substrate targeting with cytoskeletal remodeling.
We recently reported the Ca
2?- and kinase dependent
interaction between TRPM7 and the actomyosin cytoskel-
eton [93]. Very similar to the Dictyostelium myosin II
heavy chain kinases, TRPM6 and TRPM7 are capable of
phosphorylating the three mammalian alpha-helical
assembly domains of the myosin II heavy chain isoforms,
MHC-A, B, and C, at least in vitro [13]. Consequently,
kinase activity may induce myosin II ﬁlament disassembly,
affecting stress ﬁber formation and reducing actomyosin
contractility [121, 122]. Apparently, this property of alpha-
kinases has been preserved during evolution. However,
unlike the Dictyostelium MHCKs, we have shown that
TRPM6 and TRPM7 can also phosphorylate the non-heli-
cal C-terminus of MHC-B and MHC-C, which suggests
that residues phosphorylated by these mammalian alpha-
kinases are not exclusively positioned within an alpha-
helix [13].
Actomyosin contractility plays a central role in regu-
lating the assembly and disassembly of adhesive contacts,
such as focal adhesion, and invasive adhesions, such as
podosomes [123–125]. The formation of podosomes
requires a local inhibition of contractility [126]. Accord-
ingly, activation of TRPM7 in neuroblastoma cells results
in Ca
2?- and kinase-dependent podosome formation sug-
gesting a close link between TRPM7, cytoskeletal
dynamics, and cell adhesion [93]. Wei and colleagues
consistently showed that TRPM7 contributes to local Ca
2?
ﬂickers in response to mechanical stimulation, which
mediate cell polarization and steer migration [94]. In
conclusion, TRPM7 appears to act as a mechanosensor that
conducts Ca
2? upon exposure to mechanical stress which
elevates local Ca
2? levels allowing Ca
2?- and kinase-
dependent cytoskeletal rearrangements to take place [93,
101].
Regulation of (alpha-) kinase activity
Over the years, many different mechanisms have been pro-
posed to regulate the activity of CPKs. In general, kinases
adopt different conformations in their inactive and active
states [127]. For several kinases, the inactive state is stabi-
lizedbyintramolecularinteractionswithregulatorydomains
[128, 129]. Transition to the active state can occur by
association with regulatory proteins, lipids, or second mes-
sengers such as cAMP [128, 130, 131], (de)phosphorylation
by upstream phosphatases and kinases [129, 132], or auto-
phosphorylation[133].Inadditiontodirectlyinﬂuencingthe
catalytic activity of the kinase, regulatory domains may also
serve as a docking site to recruit substrates, which are
subsequently phosphorylated by the kinase [134].
Initial studies in understanding the molecular mecha-
nisms controlling the catalytic activity of alpha-kinases
have revealed that members of this kinase family are reg-
ulated by mechanisms analogous to CPKs. The regulation
of eEF2K has been the most extensively studied [52–56].
Depending on nutrient availability, eEF2K phosphorylates
eEF2 leading to an inhibition of protein synthesis. This
system is controlled by several protein kinase cascades that
lead to the phosphorylation of eEF2K which can either
inhibit or activate its catalytic activity. Two major kinases
involved in the control of metabolic processes are mTOR
and AMPK, both of which control eEF2K activity [53–56,
135]. Under conditions of nutrient deprivation, eEF2K
activity remains high to suppress protein translation, and
this occurs through the phosphorylation of Ser398 by
AMPK, a kinase whose activity is induced by high AMP/
ATP ratios in the cell [54]. Elevation of cAMP in cells also
inhibits protein translation but this pathway involves the
phosphorylation of eEF2K by PKA [136]. In contrast to
AMPK, PKA phosphorylates Ser499 of eEF2K leading to
increased enzymatic activity [137].
Other stimuli such as stress, growth factors, and mito-
gens must ensure the inhibition of eEF2K to promote
protein translation. Growth factors activate a rapamycin-
sensitive pathway involving the activation of p70S6K by
mTOR and a rapamycin-resistant pathway where ERK1/2
activate p90RSK [138]. Both p70S6K and p90RSK phos-
phorylate Ser366 which correlates with a decrease in
eEF2K activity and eEF2 phosphorylation in cell lysates.
Cellular stress induces a set of protein kinase cascades
including ones involving members of the p38 MAPK
family. These signaling pathways target eEF2K leading to
its phosphorylation on Ser359 and Ser377 [139, 140].
During mitosis, CDC2 phosphorylates Ser359 of eEF2K
[52]. The phosphorylation of these residues correlates with
dephosphorylation of eEF2 and protein translation in cells.
Thus, eEF2K is a target of multiple protein kinase cascades
to control protein synthesis under various cellular condi-
tions. It remains unknown to what extent other alpha-
kinases are also phosphorylated by protein kinases to
regulate their activity.
In addition to phosphorylation, eEF2K is activated
allosterically by Ca2
?/calmodulin which binds a region
directly N-terminalofthecatalyticdomain.Thedependence
of eEF2K on Ca
2?/calmodulin for optimal catalytic activity
led scientists to originally call this protein CaMKIII. Phos-
phorylation of activating residues by autophosphorylation
or ‘upstream’ protein kinases generates an eEF2K activity
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2?/calmodulin [141]. However,
other signaling cascades modulate the binding of Ca
2?/
calmodulin to eEF2K to regulate protein synthesis. Insulin
activates a rapamycin-sensitive mTOR pathway leading to
the phosphorylation of Ser78 nearby the calmodulin binding
domain [53]. Phosphorylation of this residue inhibits the
binding of Ca
2?/calmodulin to eEF2K preventing its acti-
vation [53]. Finally, Ryazanov and colleagues postulated
that eEF2K is activated at pH\7.4, also occurring during
hypoxia and ischemia, and might thus represent another
route in which metabolic stress inhibits protein synthesis
[62].
Two regulatory mechanisms appear common to several
members of the alpha-kinase family: (1) autophosphory-
lation, and (2) a requirement of additional domains beyond
the catalytic core for efﬁcient substrate phosphorylation.
All alpha-kinases studied to date including MHCKs,
eEF2K, TRPM6, and TRPM7 undergo autophosphoryla-
tion. Intriguingly, the level of autophosphorylation displays
a wide dynamic range with stoichiometry of phosphoryla-
tion ranging from 6 to 30 mol Pi/mol kinase [17, 36, 37].
Complete autophosphorylation does not appear to be
required for activation of MHC kinases since autophos-
phorylation of three sites (out of ten) is sufﬁcient to
activate MHCK-A [37], and myosin II phosphorylation
proceeds in parallel to MHCK-C autophosphorylation [17].
In contrast, TRPM6 and TRPM7 only phosphorylate
myosin II under conditions allowing complete autophos-
phorylation of the kinases [116]. TRPM6 and TRPM7
autophosphorylate a Ser/Thr-rich domain ﬂanking the
N-terminus of the catalytic domain. Autophosphorylation
is not required for catalytic activity per se but provides a
means for the kinase to recognize protein substrates such as
myosin II. Notably, MHCKs and eEF2K also require
additional domains for substrate recognition. The C-ter-
minus of eEF2K [51] and MHCK [36] bind directly to their
respective substrates. Deletion of these regions decreases
the rate of protein phosphorylation without affecting
the kinetics of phosphorylation of a synthetic peptide
[23, 31, 36, 51].
As mentioned earlier, the crystal structure of the
TRPM7 alpha-kinase domain has been solved [142]. Both
in solution and in crystals the kinase forms a dimer which
is essential for kinase activity [115, 142, 143]. Also, the
TRPM6 and TRPM7 kinase domain can heteromerize to
form a functional kinase [143]. The alpha-kinase domains
of TRPM6 and TRPM7 dimerize where a short stretch of
amino acids (aa1,553–1,562) at the N-terminus interacts
with key catalytic residues in the opposite monomer [143].
Interestingly, a monomeric TRPM7 kinase domain can be
fully activated by incubating it with a peptide corre-
sponding to the activation sequence spanning amino acids
1,548–1,576. Thus, the activation sequence aa1,553–1,562
plays a key role in controlling TRPM6 and TRPM7 cata-
lytic activity, and changes in conformation within this
region of the kinase by posttranslational modiﬁcations or
binding to a regulatory protein or lipid could provide an
important regulatory mechanism to control enzymatic
activity.
Alpha-kinases in health and disease
Protein kinases are important drug targets for the treatment
of human diseases such as cancer as they are often the
result of deregulated kinase-dependent signaling pathways
(reviewed in [144–146]). The majority of protein kinase
inhibitors bind to the ATP-binding pocket abolishing the
access of ATP to the protein kinase. This strategy poses a
major challenge in designing effective compounds with
suitable speciﬁcity to prevent potential side-effects due to
the blockade of other protein kinases. Since alpha-kinases
bind to the sugar and base moieties of ATP using a dif-
ferent molecular interface than CPKs [21], it may be
possible to take advantage of this feature to develop spe-
ciﬁc protein kinase inhibitors.
Among alpha-kinases, eEF2K, TRPM6, and TRPM7
have been linked to the pathogenesis of human disease. As
we previously described, eEF2K dysfunction has been
linked to cancer progression via its effect on eEF2 activity.
Several clinically applied anti-cancer drugs, such as
Doxorubicin and Ontak, inactivate eEF2 directly and
thereby inhibit protein synthesis and cell cycling, leading
to tumor cell death [65]. A few compounds have been
reported to cause cell cycle arrest by inhibition of eEF2K
of which NH125 is the most potent and speciﬁc in vitro
[147]. However, its clinical value in cancer treatment has
yet to be revealed.
TRPM6 has been identiﬁed as the gene mutated in
patients suffering from familial hypomagnesemia with
secondary hypocalcemia [87, 88]. Unfortunately, the
majority of genetic lesions are frameshift mutations which
lead to a premature arrest of the polypeptide chain and
disrupt both the channel and kinase activities. Furthermore,
Mg
2? conductance by the TRPM6 channel, rather than
kinase activity, appears related to familial hypomagnese-
mia. Hence, modulation of TRPM6 protein kinase activity
by pharmacological agents is unlikely to provide an
effective treatment of this disease.
TRPM7 has been linked to ischemic brain damage [95,
148, 149]. Oxygen and glucose deprivation in neuronal
cells is reported to mediate TRPM7 channel opening via a
ROS-dependent mechanism, and the resulting Ca
2? inﬂux
induces cell death. Whether this is due to intracellular Ca
2?
overload or a positive feedback loop in which Ca
2? inﬂux
triggers further ROS production is not known. A role for
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not been established. As we described previously, kinase
activity of TRPM7 is not required for channel activation.
The opposite, however, is a possibility that cannot be
excluded. The Ca
2? inﬂux activates downstream signaling
pathways that might implicate the TRPM7 alpha-kinase
domain as well. Hence, speciﬁc TRPM7 kinase inhibitors
are required to test this hypothesis. Although clinical
application of TRPM7 kinase inhibitors is unlikely to be
beneﬁcial in cases of ischemic brain damage, TRPM7 may
be a candidate drug target for the treatment of cancer. As
was described before, and reported in recent publications
[100, 150], changing TRPM7 expression levels affects
cancer cell proliferation. But again, the role of its kinase
domain therein remains to be established. Of current
interest is the role of TRPM7 in cell migration and inva-
sion. We have previously shown that the TRPM7 alpha-
kinase associates with the cytoskeleton at sites of cell-ECM
adhesion where it regulates the level of cytoskeletal ten-
sion, e.g. by myosin heavy chain phosphorylation, and the
formation of adhesive structures called podosomes that
permit cell invasion [93]. Knowing that TRPM7 responds
to mechanical force, and steers cell polarity by initiating
Ca
2? sparks [94], indicates that TRPM7 serves as mecha-
nosensor that senses matrix properties and locally steers
cytoskeletal remodeling to facilitate cell invasion. As the
latter appears to be kinase dependent, it is tempting to
speculate that inhibitors of the TRPM7 kinase may inter-
fere with metastasis formation.
The development of relatively speciﬁc, small cell-per-
meable inhibitors of alpha-kinases could also provide
important research tools to identify the physiological
substrates and functions of these enzymes. These com-
pounds can be used simply and rapidly and provide a
complementary approach of genetic methods. An imme-
diate question these inhibitors could help resolve is the
role of the alpha-kinase domain in controlling the channel
activity of TRPM6 and TRPM7, a debate that has been
raging since the discovery of these channels at the turn of
the century.
Conclusions and future perspectives
Alpha-kinases form a distinct family of protein kinases
with a unique domain organization and speciﬁc substrate
preference. A comprehensive search for alpha-kinase
domains encoded by eukaryotic genomes has revealed a
large number of novel alpha-kinases, many of which
remain uncharacterized. Alpha-kinases show a remarkable
functional diversity, which most likely arose by taxon
speciﬁc gene duplications and recombination with other
protein domains. To date, two members of this kinase
family, eEF2K and TRPM7, have been linked to cancer
growth and progression, while a loss of TRPM6 function
contributes to familial hypomagnesia with secondary
hypocalcemia. As the large majority of the alpha-kinase
family remain to be characterized, additional roles for this
intriguing set of proteins will undoubtedly be discovered.
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